HPHR Paper™ · No. 02

Your Nervous System Can Turn Pain Down

Understanding Endogenous Pain Inhibition and Its Clinical Significance

Author
Dr. Emmanuel Frantzis, DC, MSc, IFMCP, DACNB, DO(MP)
Published
Published September 2026
Reading time
5 min read
Level
Intermediate
Topic
Pain Neuroscience

Author

Dr. Emmanuel Frantzis

Founder, High Performance Health Restoration

Executive Summary

One of the most important advances in contemporary pain neuroscience has been the recognition that the nervous system possesses intrinsic mechanisms capable of regulating nociceptive transmission before pain reaches conscious awareness. Among the best-characterized of these systems is the descending analgesic network involving the periaqueductal grey (PAG), the rostroventromedial medulla (RVM), and the dorsal horn of the spinal cord.¹² Rather than functioning solely as an ascending sensory pathway, the nervous system continuously balances incoming nociceptive information through descending facilitatory and inhibitory influences. Understanding these endogenous regulatory mechanisms broadens clinical reasoning by recognizing that persistent pain may reflect not only the magnitude of nociceptive input, but also differences in how that information is processed within the central nervous system.

Scientific Foundation

The traditional explanation of pain emphasizes the transmission of nociceptive information from peripheral tissues to the brain. Although this ascending pathway remains fundamental to pain physiology, it represents only one component of a highly integrated regulatory system. As discussed in the preceding paper, communication within the nervous system is fundamentally bidirectional. In addition to descending pathways that continuously influence spinal nociceptive processing, the central nervous system possesses intrinsic mechanisms capable of suppressing, amplifying, or modulating incoming sensory information before it contributes to conscious pain perception.¹² Appreciating these endogenous regulatory systems provides an important foundation for understanding why individuals exposed to similar nociceptive stimuli may experience pain very differently.

Landmark Concepts

The Physiology of Endogenous Pain Inhibition Among the principal structures involved in endogenous pain modulation is the periaqueductal grey (PAG), a midbrain region that integrates information from cortical, subcortical, and limbic structures before influencing descending brainstem pathways. Through projections to the rostroventromedial medulla (RVM) and subsequently to the dorsal horn of the spinal cord, the PAG forms part of one of the nervous system’s major descending analgesic systems.¹² These pathways are regulated through complex interactions involving endogenous opioids, γ-aminobutyric acid (GABA), serotonin, noradrenaline, glutamate, and numerous neuromodulatory systems. Their function extends beyond pain inhibition alone, contributing to behavioural adaptation, stress responses, defensive behaviour, and homeostatic regulation. Rather than operating as a simple “pain switch,” the PAG–RVM network continuously adjusts nociceptive processing according to physiological state, behavioural priorities, and environmental context. Evidence for Descending Analgesia Important mechanistic insight into this system was provided by Lau, Winters, and Vaughan (2020)², who examined the cellular physiology underlying endogenous opioid regulation of the PAG–RVM descending analgesic pathway. Their work demonstrated that activation of μ-opioid receptors suppresses inhibitory GABAergic interneurons within the PAG, effectively disinhibiting projection neurons that activate descending analgesic pathways. This elegant mechanism illustrates how endogenous opioid systems facilitate pain inhibition not simply by reducing neuronal activity, but by selectively removing inhibitory influences within key components of the descending modulatory network. These findings significantly advanced our understanding of the neurophysiology underlying endogenous pain inhibition and provided a mechanistic framework linking molecular neuroscience with systems-level regulation of nociceptive processing. Clinical Evidence Experimental neurophysiology becomes particularly meaningful when corresponding mechanisms can be demonstrated in clinical populations. A landmark investigation by Julien and colleagues (2005)¹ compared endogenous pain inhibition in individuals with fibromyalgia, chronic low back pain, and healthy controls using conditioned pain modulation paradigms. Healthy participants and individuals with chronic low back pain demonstrated measurable endogenous inhibitory responses, whereas participants with fibromyalgia exhibited significantly impaired endogenous pain inhibition. These observations suggest that alterations in intrinsic inhibitory systems may contribute to persistent pain in selected clinical populations. Importantly, such findings should not be interpreted as providing a universal explanation for chronic pain. Rather, they illustrate that differences in endogenous regulation represent one of several physiological mechanisms capable of influencing the pain experience.

Current Evidence

Recent investigations have continued to refine our understanding of the PAG–RVM–spinal cord network while revealing an increasingly complex organization of descending pain modulation. Contemporary neurophysiological and neuroimaging studies demonstrate that endogenous analgesia emerges through coordinated interactions involving the periaqueductal grey, rostroventromedial medulla, locus coeruleus, anterior cingulate cortex, anterior insula, amygdala, hypothalamus, and prefrontal cortex. These interconnected systems integrate nociceptive information with attention, emotional state, behavioural context, stress responses, and autonomic regulation, highlighting the distributed nature of endogenous pain control.³⁻⁵ Recent research has also emphasized that descending modulation reflects a dynamic balance between inhibitory and facilitatory influences rather than a purely analgesic system. This evolving perspective helps explain why pain regulation varies across individuals and clinical conditions while reinforcing one of the central themes of this paper: the nervous system is continuously regulating nociceptive information long before pain reaches conscious awareness.

Discussion

The recognition that the nervous system possesses intrinsic inhibitory mechanisms has fundamentally expanded contemporary approaches to pain physiology. Persistent pain can no longer be understood solely by examining the magnitude of nociceptive input arising from peripheral tissues. Instead, the experience of pain reflects continuous interaction between ascending sensory information and descending regulatory systems that modify nociceptive transmission according to physiological, cognitive, emotional, and behavioural influences. This perspective does not diminish the importance of tissue pathology. Rather, it places tissue injury within the context of an adaptive nervous system whose regulatory capacity may differ considerably between individuals. Consequently, two people presenting with similar structural findings or nociceptive input may experience markedly different pain because the nervous systems responsible for processing that information are functioning differently. Understanding endogenous pain inhibition therefore encourages clinicians to broaden their assessment beyond the tissues themselves and to consider how the nervous system regulates incoming sensory information. This represents an important step toward more comprehensive clinical reasoning and reinforces one of the central themes developed throughout this series: understanding pain begins with understanding the nervous system.

HPHR Clinical Perspective™

If two individuals receive similar nociceptive input, could differences in endogenous pain inhibition contribute to profoundly different pain experiences? More importantly, are we assessing the tissues alone, or are we also considering the nervous system responsible for regulating them?

Primary References

Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005). Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain, 114(1–2), 295–302. https://doi.org/10.1016/j.pain.2004.12.032 Lau, B. K., Winters, B. L., & Vaughan, C. W. (2020). Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway. British Journal of Pharmacology, 177(10), 2320–2332. https://doi.org/10.1111/bph.14982 Bushnell, M. C., Čeko, M., & Low, L. A. (2023). (Contemporary review of descending pain modulation and endogenous analgesia—final APA citation to be verified.) Recent review of brainstem pain modulatory networks (2024). (Final APA citation to be verified during publication review.) Recent systems neuroscience review of endogenous pain regulation (2025). (Final APA citation to be verified during publication review.)
endogenous pain inhibitionperiaqueductal greyconditioned pain modulationfibromyalgiadescending analgesia

Your pathway

Continue Learning

HPHR is a structured learning environment. Each step below carries the same subject a little further — from the filmed episode, through the written papers, into the wider topic, and finally into practice.

  1. Companion Academy Lesson

    Coming Soon

    The Academy Master Lesson for this paper is in production.

  2. Previous Paper

    Pain Doesn’t Only Travel Up

    Where this line of reasoning began.

  3. Next Paper

    When Healing Isn’t Enough

    The next step in the sequence.

  4. Related Topic

    Pain Neuroscience

    Every episode and paper in this cluster.

  5. Future Book

    The Adaptive Brain™

    Coming Soon

  6. Apply for Membership

    Have this science applied to your own physiology.

    Clinician-guided restoration, built around your findings.

    Apply

Newsletter

Receive practical neuroscience and health restoration insights.

Membership

Restoration guided by this science.

Explore Membership